Sandbox tachy: Difference between revisions
Jump to navigation
Jump to search
Gerald Chi (talk | contribs) mNo edit summary |
Gerald Chi (talk | contribs) |
||
(One intermediate revision by the same user not shown) | |||
Line 5: | Line 5: | ||
==FIRE: Focused Initial Rapid Evaluation== | ==FIRE: Focused Initial Rapid Evaluation== | ||
A Focused Initial Rapid Evaluation (FIRE) should be performed to identify patients in need of immediate intervention. | A Focused Initial Rapid Evaluation (FIRE) should be performed to identify patients in need of immediate intervention. | ||
{{familytree/start | {{familytree/start}} | ||
{{familytree | | | | | | | | | | | | | A01 | | | | A01=[[Tachycardia]] }} | {{familytree | | | | | | | | | | | | | A01 | | | | A01=[[Tachycardia]] }} | ||
{{familytree | | | | | | | | | | | | | |!| | | | | | }} | {{familytree | | | | | | | | | | | | | |!| | | | | | }} | ||
Line 11: | Line 11: | ||
{{familytree | | | | | | | | | B01 | | | | | | B02 | B01=Pulse | B02=No Pulse }} | {{familytree | | | | | | | | | B01 | | | | | | B02 | B01=Pulse | B02=No Pulse }} | ||
{{familytree | | | | | | | | | |!| | | | | | | |!| | }} | {{familytree | | | | | | | | | |!| | | | | | | |!| | }} | ||
{{familytree | | | | | | | | | X01 | | | | | | X02 | X01=<b>Evaluate and treat instability:</b> |X02=Pulseless | {{familytree | | | | | | | | | X01 | | | | | | X02 | X01=<b>Evaluate and treat instability:</b> |X02=Pulseless VT or PEA}} | ||
{{familytree |boxstyle=border-top: 0px | | | | | | | | | C01 | | | | | | C02 | C01=<div style="text-align: left;"> | {{familytree |boxstyle=border-top: 0px | | | | | | | | | C01 | | | | | | C02 | C01=<div style="text-align: left;"> | ||
❑ 12-lead ECG, don't delay therapy <BR> | ❑ 12-lead ECG, don't delay therapy <BR> | ||
Line 49: | Line 49: | ||
❑ <u>Antiarrhythmic infusion for stable wide-QRS tachycardia:</u> <br> | ❑ <u>Antiarrhythmic infusion for stable wide-QRS tachycardia:</u> <br> | ||
: ❑ Procainamide IV Dose: <br> | : ❑ Procainamide IV Dose: <br> | ||
:: ❑ 20-50mg/min until | :: ❑ 20-50mg/min until: <br> | ||
::: ❑ Arrhythmia suppressed <br> | |||
::: ❑ Hypotension ensues <br> | |||
::: ❑ QRS duration increases 50% <br> | |||
::: ❑ Maximum dose 17mg/kg given. <br> | |||
:: ❑ Maintenance infusion: 1-4 mg/min. <br> | :: ❑ Maintenance infusion: 1-4 mg/min. <br> | ||
:: ❑ Avoid if prolonged QT or CHF. <br> | :: ❑ Avoid if prolonged QT or CHF. <br> |
Latest revision as of 20:38, 2 March 2015
FIRE: Focused Initial Rapid Evaluation
A Focused Initial Rapid Evaluation (FIRE) should be performed to identify patients in need of immediate intervention.
Tachycardia | |||||||||||||||||||||||||||||||||||||||
Pulse | No Pulse | ||||||||||||||||||||||||||||||||||||||
Evaluate and treat instability: | Pulseless VT or PEA | ||||||||||||||||||||||||||||||||||||||
❑ 12-lead ECG, don't delay therapy
| Proceed to ACLS Cardiac Arrest Algorithm | ||||||||||||||||||||||||||||||||||||||
Hemodynamic stable | Hemodynamic unstable | ||||||||||||||||||||||||||||||||||||||
Check duration of QRS | Synchronized cardioversion: Consider sedation If regular narrow complex, consider adenosine | ||||||||||||||||||||||||||||||||||||||
Wide complex tachycardia (≥120 ms) | Narrow complex tachycardia (<120 ms) | ❑ Doses/details of synchronized cardioversion:
❑ Adenosine IV dose:
| |||||||||||||||||||||||||||||||||||||
Consider expert consultation Consider antiarrhythmic infusion Consider adenosine only if monomorphic and regular | Vagal maneuvers Beta-Blockers or calcium channel blocker Consider expert consultation Adenosine if regular | Proceed to Hemodynamic instability resident survival guide | |||||||||||||||||||||||||||||||||||||
❑ Antiarrhythmic infusion for stable wide-QRS tachycardia:
| Proceed to Narrow complex tachycardia resident survival guide | ||||||||||||||||||||||||||||||||||||||
Proceed to Wide complex tachycardia resident survival guide | |||||||||||||||||||||||||||||||||||||||